David Henry's JCSO Podcast

David Henry's JCSO podcast, May 2016


 

For the May podcast for The Journal of Community and Supportive Oncology, Dr David Henry highlights original reports on the prognostic significance of HPV status in postoperative squamous cell carcinoma of the head and neck, the contributions of caregivers in American Indian cancer patients, and the omission of dexamethasone from antiemetics treatment in breast cancer patients with hepatitis B infection or diabetes. He also describes how providers at a comprehensive cancer center devised a framework for implementing survivorship care planning, and, in keeping with the ‘how we do it’ theme, he discusses an article by 2 practicing on oncologists on managing and treating multiple myeloma. The line-up is rounded off with articles on the effects of exercise interventions during different treatments in patients with breast cancer, the approval of trabectedin for some forms of advanced soft tissue sarcoma, and a Case Report on a rare case of hypoglycemia induced by a classical gastro-intestinal stromal tumor.

Listen to the podcast below.

Recommended Reading

Advances in the management of multiple myeloma
MDedge Hematology and Oncology
Effects of exercise interventions during different treatments in breast cancer
MDedge Hematology and Oncology
Omission of dexamethasone from antiemetic treatment for highly emetogenic chemotherapy in breast cancer patients with hepatitis B infection or diabetes mellitus
MDedge Hematology and Oncology
Prognostic significance of HPV status in postoperative squamous-cell carcinoma of the head and neck
MDedge Hematology and Oncology
Culture-broker and medical decoder: contributions of caregivers in American Indian cancer trajectories
MDedge Hematology and Oncology
Paraneoplastic syndrome and underlying breast cancer: a worsening rash despite initiation of chemotherapy
MDedge Hematology and Oncology
One-size-fits-all approach no good for low-risk ET
MDedge Hematology and Oncology
Proteins may be targets for malaria vaccines
MDedge Hematology and Oncology
Team simplifies synthesis of anticancer agent
MDedge Hematology and Oncology
IMF denounces report on newer MM drugs
MDedge Hematology and Oncology